EDITAS MEDICINE, INC. Increase (Decrease) in Accounts Payable
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Accounts Payable of $1.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$58.00K, a 104.61% decline year-over-year.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.73M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$558.00K.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$3.56M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for fiscal 2025 was -$2.89M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for fiscal 2024 was -$2.29M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for fiscal 2023 was -$1.49M, a 134.16% decline from fiscal 2022.
- EDITAS MEDICINE, INC. increase (decrease) in accounts payable for fiscal 2022 was $4.37M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.67M 10-Q · filed 2026-08-05 | $1.11M derived: sum of 3 quarters · filed 2026-08-05 | -$2.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.73M 10-Q · filed 2026-05-05 | $1.17M derived: sum of 2 quarters · filed 2026-05-05 | -$2.39M derived: sum of 3 quarters · filed 2026-05-05 | -$1.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$4.12M derived: sum of 2 quarters · filed 2026-03-09 | -$2.86M derived: sum of 3 quarters · filed 2026-08-05 | -$2.89M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.30M derived: sum of 2 quarters · filed 2026-08-05 | -$2.33M 10-Q · filed 2025-11-10 | -$9.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.23M 10-Q · filed 2026-08-05 | -$5.77M derived: sum of 3 quarters · filed 2026-08-05 | -$7.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$27.00K 10-Q · filed 2026-05-05 | -$7.03M derived: sum of 2 quarters · filed 2026-05-05 | -$8.28M derived: sum of 3 quarters · filed 2026-05-05 | -$857.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$8.25M derived: sum of 2 quarters · filed 2026-03-09 | -$830.00K derived: sum of 3 quarters · filed 2026-03-09 | -$2.29M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.17M derived: sum of 2 quarters · filed 2025-11-10 | $4.71M 10-Q · filed 2025-11-10 | $2.12M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.97M 10-Q · filed 2025-08-12 | $3.37M derived: sum of 3 quarters · filed 2025-08-12 | $5.73M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$1.46M 10-Q · filed 2025-05-12 | -$4.05M derived: sum of 2 quarters · filed 2025-05-12 | -$1.69M derived: sum of 3 quarters · filed 2025-05-12 | -$2.39M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$236.00K derived: sum of 2 quarters · filed 2025-03-05 | -$935.00K derived: sum of 3 quarters · filed 2025-03-05 | -$1.49M 10-K · filed 2025-03-05 |
| 2023-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.66M derived: sum of 2 quarters · filed 2024-11-04 | $1.10M 10-Q · filed 2024-11-04 | $3.80M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.26M 10-Q · filed 2024-08-07 | $1.44M derived: sum of 3 quarters · filed 2025-03-05 | $1.86M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | -$557.00K 10-Q · filed 2024-05-08 | $2.14M derived: sum of 2 quarters · filed 2025-03-05 | $2.56M derived: sum of 3 quarters · filed 2025-03-05 | $4.04M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $3.12M derived: sum of 2 quarters · filed 2025-03-05 | $4.60M derived: sum of 3 quarters · filed 2025-03-05 | $4.37M 10-K · filed 2025-03-05 |
| 2022-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.90M derived: sum of 2 quarters · filed 2023-11-03 | $1.67M 10-Q · filed 2023-11-03 | $3.51M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.25M 10-Q · filed 2023-08-02 | $3.09M derived: sum of 3 quarters · filed 2024-02-28 | $1.93M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$229.00K 10-Q · filed 2023-05-05 | $1.61M derived: sum of 2 quarters · filed 2024-02-28 | $450.00K derived: sum of 3 quarters · filed 2024-02-28 | -$3.38M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $679.00K derived: sum of 2 quarters · filed 2024-02-28 | -$3.16M derived: sum of 3 quarters · filed 2024-02-28 | -$1.14M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$5.00M derived: sum of 2 quarters · filed 2022-11-02 | -$2.98M 10-Q · filed 2022-11-02 | -$1.68M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.82M 10-Q · filed 2022-08-03 | -$516.00K derived: sum of 3 quarters · filed 2023-02-22 | -$1.99M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $2.02M 10-Q · filed 2022-05-04 | $3.32M derived: sum of 2 quarters · filed 2023-02-22 | $1.85M derived: sum of 3 quarters · filed 2023-02-22 | -$1.90M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$171.00K derived: sum of 2 quarters · filed 2023-02-22 | -$3.91M derived: sum of 3 quarters · filed 2023-02-22 | $855.00K 10-K · filed 2023-02-22 |
| 2020-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$5.21M derived: sum of 2 quarters · filed 2021-11-09 | -$447.00K 10-Q · filed 2021-11-09 | -$1.18M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.03M 10-Q · filed 2021-08-05 | $295.00K derived: sum of 3 quarters · filed 2022-02-24 | $2.76M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $4.77M 10-Q · filed 2021-05-06 | $4.04M derived: sum of 2 quarters · filed 2022-02-24 | $6.50M derived: sum of 3 quarters · filed 2022-02-24 | $4.42M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$731.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.73M derived: sum of 2 quarters · filed 2022-02-24 | -$352.00K derived: sum of 3 quarters · filed 2022-02-24 | $274.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $379.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.00M 10-Q · filed 2020-11-06 | $1.12M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$1.46M 10-Q · filed 2020-08-07 | -$1.35M derived: sum of 3 quarters · filed 2021-02-26 | -$663.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $626.00K 10-Q · filed 2020-05-08 | $739.00K derived: sum of 2 quarters · filed 2021-02-26 | $1.42M derived: sum of 3 quarters · filed 2021-02-26 | -$2.69M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $796.00K derived: sum of 2 quarters · filed 2021-02-26 | -$3.31M derived: sum of 3 quarters · filed 2021-02-26 | $1.78M 10-K · filed 2021-02-26 |
| 2018-09-30 | $683.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.43M derived: sum of 2 quarters · filed 2019-11-12 | $1.67M 10-Q · filed 2019-11-12 | -$2.41M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | -$4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $984.00K 10-Q · filed 2019-08-07 | -$3.09M derived: sum of 3 quarters · filed 2020-02-26 | -$3.90M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $5.09M 10-Q · filed 2019-05-08 | $1.02M derived: sum of 2 quarters · filed 2020-02-26 | $214.00K derived: sum of 3 quarters · filed 2020-02-26 | -$6.50M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$4.88M derived: sum of 2 quarters · filed 2020-02-26 | -$11.59M derived: sum of 3 quarters · filed 2020-02-26 | -$1.51M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$803.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$7.51M derived: sum of 2 quarters · filed 2018-11-08 | $2.56M 10-Q · filed 2018-11-08 | $3.72M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.37M 10-Q · filed 2018-08-07 | $4.52M derived: sum of 3 quarters · filed 2019-03-01 | $2.36M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $10.08M 10-Q · filed 2018-05-04 | $11.23M derived: sum of 2 quarters · filed 2019-03-01 | $9.07M derived: sum of 3 quarters · filed 2019-03-01 | $12.79M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$1.01M derived: sum of 2 quarters · filed 2019-03-01 | $2.71M derived: sum of 3 quarters · filed 2019-03-01 | $3.25M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.55M derived: sum of 2 quarters · filed 2017-11-08 | $2.10M 10-Q · filed 2017-11-08 | $1.74M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.26M 10-Q · filed 2017-08-09 | $3.90M derived: sum of 3 quarters · filed 2018-03-08 | -$1.68M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $544.00K 10-Q · filed 2017-05-15 | $188.00K derived: sum of 2 quarters · filed 2018-03-08 | -$5.39M derived: sum of 3 quarters · filed 2018-03-08 | $720.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$5.94M derived: sum of 2 quarters · filed 2018-03-08 | $176.00K derived: sum of 3 quarters · filed 2018-03-08 | -$1.44M 10-K · filed 2018-03-08 |
| 2015-09-30 | -$5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $532.00K derived: sum of 2 quarters · filed 2016-11-09 | -$1.08M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $6.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $4.50M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$1.61M 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $2.19M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |